Results 81 to 90 of about 12,603 (200)

Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs [PDF]

open access: yes, 2005
Background Stopping antipsychotic treatment can interrupt improvement and exacerbate the illness. The reasons for discontinuing treatment during controlled clinical trials were analyzed to explore this phenomenon.
Adams David H   +2 more
core   +2 more sources

The Psychiatric‐Metabolic Interface: Exploring the Interplay Between Mental Disorders and Metabolic Syndrome

open access: yesMental Illness, Volume 2026, Issue 1, 2026.
Psychiatric disorders affect a person′s mental health, causing emotional and physical disturbances. Metabolic syndrome (MetS) is a medical condition characterized by metabolic abnormalities and health complications. Research suggests that individuals with specific psychiatric conditions are more likely to develop MetS.
Linda Elias   +11 more
wiley   +1 more source

Зипраcидон для внутримышечного введения: опыт и возможности применения в психиатрии

open access: yesСовременная терапия психических расстройств, 2017
В обзоре представлены данные об эффективности современного атипичного антипсихотика зипрасидона для внутримышечного применения при купировании острого психомоторного возбуждения различного генеза (шизофрения, биполярное аффективное расстройство ...
Медведев, В.Э.   +1 more
doaj   +1 more source

Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia

open access: yesNeuropsychiatric Disease and Treatment, 2011
Hongyan Zhang1, Huafang Li2, Liang Shu1, Niufan Gu2, Gang Wang3, Yongzhen Weng3, Shiping Xie4, Xinbao Zhang4, Ting Li5, Cui Ma5, Wei Yu6, Bruce Parsons7, Manjula Schou81Institute of Mental Health, Peking University, Beijing, China; 2Shanghai Mental ...
Hongyan Zhang   +3 more
doaj  

Comparison of intramuscular haloperidol and other short-acting injectable antipsychotics for management of acute agitation in an adult inpatient psychiatry unit [PDF]

open access: yesMental Health Clinician
Introduction There is no consensus on the optimal antipsychotic for acute agitation. Whereas haloperidol is frequently used and has proven efficacy, second generation antipsychotics show similar efficacy and improved safety and tolerability.
Sarah Gamcsik, PharmD   +1 more
doaj   +1 more source

Iloperidone - new second generation antipsychotic: Pharmacological aspects and schizophrenia clinical management [PDF]

open access: yes, 2018
Iloperidone is a new atypical antipsychotic drug approved by FDA for the treatment of schizophrenia. In this article, we searched the published randomized controlled trials (RCT) and other literature to review the efficacy and safety of iloperidone using
Mishriky, Raafat, Reyad, Ayman Antoun
core   +1 more source

PREGNANCY AND ATYPICAL ANTIPSYCHOTICS [PDF]

open access: yes, 2009
Scientific research aiming at discovering new generations of effective medications is a common practice in medicine, and psychiatric research is no exception. Antipsychotics are used to treat chronic mental illnesses such as schizophrenia.
Daniela Petrić   +4 more
core   +1 more source

Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases

open access: yes
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 3, March 2026.
Karissa Chow   +4 more
wiley   +1 more source

Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials

open access: yesBMC Psychiatry, 2009
Background How long an antipsychotic is effective in maintaining response is important in choosing the correct treatment for people with schizophrenia.
Liu Lin   +4 more
doaj   +1 more source

NEW GENERATION VS. FIRST GENERATION ANTIPSYCHOTICS DEBATE: PRAGMATIC CLINICAL TRIALS AND PRACTICE-BASED EVIDENCE [PDF]

open access: yes, 2009
There has been significant confusion about the relative advantage of new generation antipsychotics over first generation antipsychotics as well as of clinical trials performed to evaluate their efficacy vs. those designed to evaluate their effectiveness.
Miro Jakovljević
core   +1 more source

Home - About - Disclaimer - Privacy